User profiles for SA Klassen
 | Stephen A. KlassenBrock University Verified email at brocku.ca Cited by 3084 |
[HTML][HTML] The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis
To determine the effect of COVID-19 convalescent plasma on mortality, we aggregated
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-…
patient outcome data from 10 randomized clinical trials, 20 matched control studies, 2 dose-…
Use of convalescent plasma in COVID‐19 patients with immunosuppression
JW Senefeld, SA Klassen, SK Ford, KA Senese… - …, 2021 - Wiley Online Library
In the absence of effective countermeasures, human convalescent plasma has been widely
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …
used to treat severe acute respiratory syndrome coronavirus 2, the causative agent of novel …
[HTML][HTML] Convalescent plasma therapy for COVID-19: a graphical mosaic of the worldwide evidence
SA Klassen, JW Senefeld, KA Senese… - Frontiers in …, 2021 - frontiersin.org
Convalescent plasma has been used worldwide to treat patients hospitalized with coronavirus
disease 2019 (COVID-19) and prevent disease progression. Despite global usage, …
disease 2019 (COVID-19) and prevent disease progression. Despite global usage, …
Safety update: COVID-19 convalescent plasma in 20,000 hospitalized patients
Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …
[HTML][HTML] Early safety indicators of COVID-19 convalescent plasma in 5000 patients
…, JW Senefeld, KA Bruno, SA Klassen… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …
[HTML][HTML] Convalescent plasma antibody levels and the risk of death from Covid-19
Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …
under the presumption that such plasma contains potentially therapeutic …
Effect of convalescent plasma on mortality among hospitalized patients with COVID-19: initial three-month experience
Importance Passive antibody transfer is a longstanding treatment strategy for infectious
diseases that involve the respiratory system. In this context, human convalescent plasma has …
diseases that involve the respiratory system. In this context, human convalescent plasma has …
[HTML][HTML] Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study
…, N van Helmond, MA Golafshar, SA Klassen… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
Background: The US Food and Drug Administration authorized COVID-19 convalescent
plasma (CCP) therapy for hospitalized COVID-19 patients via the Expanded Access Program (…
plasma (CCP) therapy for hospitalized COVID-19 patients via the Expanded Access Program (…
[HTML][HTML] Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors
…, JW Senefeld, MM Petersen, SA Klassen… - Nature …, 2021 - nature.com
Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…
